Schmidt Eric Thomas
- SEC CIK
- 0001754403
No open-market purchases or sales filed in the past year.
Current role at each company
- RVMD Revolution Medicines, Inc.Directoras of Jun 12, 2023
- RLMD Relmada Therapeutics, Inc.Directoras of May 30, 2023
- ALLO Allogene Therapeutics, Inc.Chief Financial Officeras of Mar 24, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schmidt Eric Thomas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALLO Allogene Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 (view filing) | Mar 15 | 2 days | Schmidt Eric ThomasChief Financial Officer | SSale | −11.5K | $7.63 | −$87.5K | −10.2%100.5K after |